Ignite Creation Date:
2025-12-24 @ 11:34 PM
Ignite Modification Date:
2026-01-03 @ 1:45 PM
Study NCT ID:
NCT05245656
Status:
RECRUITING
Last Update Posted:
2024-08-06
First Post:
2022-02-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study Comparing Rituximab/Bendamustin(RB) Alternating With Rituximab/Bendamustin/Cytarabin(RBAC) With RB Therapy in Elderly Patients With Mentle Cell Lymphoma
Sponsor:
Kim, Seok Jin
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-10-18
Start Date Type:
ACTUAL
Primary Completion Date:
2029-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2022-02-08
First Submit QC Date:
None
Study First Post Date:
2022-02-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-03
Last Update Post Date:
2024-08-06
Last Update Post Date Type:
ACTUAL